Please assess the completion status of the following clinical trial:

Trial Title: Injection Therapy in Patients With Lateral Epicondylitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. aged 20-60 years,~2. had a clinical diagnosis of lateral epicondylitis, defined as pain over the lateral humeral epicondyle of at least 6 months' duration,~3. provoked by palpation and resisted wrist/middle finger extension or gripping,~4. participants needed to score at least 30/100 on Visual analogue scale (VAS),~5. be able to understand enough Turkish to complete the outcome questionnaire.~Exclusion Criteria:~1. Any treatment for their elbow pain by a health care practitioner within the preceding 6 months,~2. Concomitant neck or other arm pain causing disability or requiring treatment within the last 6 months,~3. Clinical evidence of other primary sources of lateral elbow pain,~4. Upper limb fractures within the preceding 10 years,~5. Prior elbow surgery~6. Elbow steroid injection in the past 3 months~7. Systemic inflammatory disorder or malignancy,~8. Pregnancy or breastfeeding

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Hyaluronic acid injection group (Type: EXPERIMENTAL): This is the study group in whom Hyaluronic acid injection was injected at lateral epicondylitis site.
- Prolotherapy injection group (Type: ACTIVE_COMPARATOR): This is the control group in whom prolotherapy injection was given at lateral epicondyle site.

Based on this trial design, predict the completion outcome and termination type (if applicable).